The takeaway is clear: While smaller-cap stocks that don’t qualify for index inclusion (grey dots on the left) have a wider spread in their short interest, there appears to be a “floor” of 1% short ...

XPG has done a great job with the Valor Air Pro mid-tower case, offering great value, good performance, and including four ...

An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The FDA has greenlighted Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s ...

An observational study was conducted across three Spanish hospitals to compare two glucocorticoid regimens in treating 151 patients newly diagnosed with giant cell arteritis (mean age, 74.6 years; 71% ...

Christian has three years of experience writing in the gaming industry, including guides and reviews, for publications such as Dualshockers, Attack of the Fanboy, and PC Invasion. He has been an avid ...

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.

Sarah Burris is a long-time veteran of political campaigns, having worked as a fundraiser and media director across the United States. She transitioned into reporting while working for Rock the Vote, ...

Fully Equipped's Johnny Wunder and Jake Morrow are joined by Softspikes Charles Woodward to discuss how combo sets can improve your swing's efficiency. DC March Against Trump Draws Huge Turnout ...

All five patients in a trial with recurrent glioblastoma given a combination of ImmunityBio's (NASDAQ:IBRX) natural killer (NK) cell therapy Anktiva and Novocure's (NASDAQ:NVCR) Optune Gio Tumor ...

Update 7/31/25 4:10pm PT: Hours after this article was published, OpenAI said it removed the feature from ChatGPT that allowed users to make their public conversations discoverable by search engines.

Dr. David Ezra Gordon is an Assistant Professor at the Emory University School of Medicine. He earned his Bachelor of Science from Cornell University and Ph.D. from the University of Cambridge. Gordon ...